Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Endobronchial Ultrasound Versus Mediastinoscopy in Patients With Non-Small Cell Lung Cancer (NSCLC) [NA]
The study comparing endobronchial ultrasound-guided staging to mediastinoscopy in patients with non-small cell lung cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2018-03-27Clinical Trial Update: Intervention of Engineered Immune Effector T Cells Against Lung Cancer [Phase 1, Phase 2]
The Phase 1/Phase 2 trial of engineered immune effector T cells for lung cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2018-03-22Clinical Trial Update: Treatment Patterns, Outcomes and Resource Use Study for Advanced Stage Non-Small Cell Lung Cancer (Squamous and Non-squamous) in the Kingdom of Saudi Arabia and United Arab Emirates
This is a completed observational trial update examining treatment patterns, outcomes and resource use in advanced-stage non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Integrated Versus Standard Palliative Care in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) [NA]
The trial compares integrated palliative care versus standard palliative care in patients with advanced non-small cell lung cancer. The stud…
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment [Phase 1]
A Phase 1 safety study of the investigational drug MM-151 in patients with advanced solid tumors that have resisted standard treatment has c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
A Mayo Clinic trial update on isolating and testing circulating tumor cells using the ClearCell FX EP+ System in lung cancer; the study stat…
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer [NA]
The clinical trial evaluating Dignity Therapy/Life Plan for patients with pancreatic cancer and Non-Small-Cell Lung Cancer has completed.
-
CLINICAL_TRIALS research · 2018-03-21Clinical Trial Update: Effects of Nonintubated Thoracoscopic Lobectomy on Lung Protection [NA]
Clinical trial update on nonintubated thoracoscopic lobectomy for patients with non-small cell lung cancer, focusing on potential lung-prote…
-
CLINICAL_TRIALS trial_result · 2018-03-20Clinical Trial Update: Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
This update reports the completion of a Phase 1/2 trial of an RNActive-derived cancer vaccine in stage IIIB/IV non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2018-03-19Clinical Trial Update: Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) [Phase 1, Phase 2]
Clinical trial update on a phase 1/2 study of defactinib plus pembrolizumab in advanced solid tumors, including non-small cell lung cancer, …
-
CLINICAL_TRIALS withdrawal · 2018-03-16Clinical Trial Update: MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial evaluating durvalumab (MEDI4736) in combination with selumetinib for KRAS-mutant non-small cell lung cancer has been withdra…
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants [Phase 3]
A phase 3 trial comparing first-line alectinib to crizotinib in treatment-naive ALK-positive advanced non-small cell lung cancer has complet…
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma [NA]
This document reports the completion of an open-label trial of perifosine in patients with solid tumors or multiple myeloma, including non-s…
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC [Phase 2]
Phase II trial evaluating pulsed paclitaxel (Taxol) with concurrent thoracic radiotherapy and adjuvant chemotherapy in stage III non-small c…
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating safety and preliminary efficacy of combining selumetinib with standard first-line therapy in locally advanced or me…
-
CLINICAL_TRIALS research · 2018-03-13Clinical Trial Update: A Study of BCD-135 in Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 clinical trial update for BCD-135 in patients with advanced solid tumors, including melanoma and non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Osimertinib as First-line Therapy for Patients With Late-stage Lung Cancer [Phase 2]
Phase 2 trial evaluating osimertinib as first-line therapy for patients with late-stage non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Understanding Mechanisms of Acquired Resistance to BIBW2992 [NA]
Completed clinical trial investigating mechanisms of acquired resistance to afatinib (BIBW2992) in EGFR-mutant non-small cell lung cancer. R…
-
CLINICAL_TRIALS research · 2018-03-09Clinical Trial Update: Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating an anti-angiogenesis agent in combination with an EGFR-TKI for advanced non-squamous non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy [Phase 2]
A Phase 2 trial evaluating captopril in patients with non-small cell lung cancer or limited-stage small cell lung cancer previously treated …
-
CLINICAL_TRIALS research · 2018-03-08Clinical Trial Update: Liquid Biopsy for Detection of Driver Mutation in NSCLC
This document provides an update on a clinical trial evaluating liquid biopsy for detection of driver mutations in non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2018-03-05Clinical Trial Update: Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating oxaliplatin with capecitabine and concurrent radiation therapy in non-small cell lung cancer; the study st…
-
CLINICAL_TRIALS research · 2018-03-05Clinical Trial Update: Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients
This clinical trial update reports on the correlation between drug sensitivity measured in patient-derived organoids and actual clinical res…
-
CLINICAL_TRIALS trial_result · 2018-03-05Clinical Trial Update: Afatinib Genomic Landscape
A clinical trial update on afatinib exploring its genomic landscape in non-small cell lung cancer reports a terminated study (NCT02491775).
-
CLINICAL_TRIALS trial_result · 2018-03-05Clinical Trial Update: Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating standard chemotherapy with blueberry powder for non-small cell lung cancer has been terminated.